- Home
- VXRT vs OCCI Comparison
VXRT vs OCCI Comparison
Compare VXRT & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- OCCI
- Stock Information
- Founded
- VXRT N/A
- OCCI N/A
- Country
- VXRT United States
- OCCI United States
- Employees
- VXRT N/A
- OCCI N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- VXRT Health Care
- OCCI Finance
- Exchange
- VXRT Nasdaq
- OCCI Nasdaq
- Market Cap
- VXRT 200.3M
- OCCI 123.6M
- IPO Year
- VXRT N/A
- OCCI N/A
- Fundamental
- Price
- VXRT $0.81
- OCCI $7.38
- Analyst Decision
- VXRT Strong Buy
- OCCI
- Analyst Count
- VXRT 2
- OCCI 0
- Target Price
- VXRT $3.00
- OCCI N/A
- AVG Volume (30 Days)
- VXRT 1.1M
- OCCI 115.8K
- Earning Date
- VXRT 10-31-2024
- OCCI 12-11-2023
- Dividend Yield
- VXRT N/A
- OCCI 24.32%
- EPS Growth
- VXRT N/A
- OCCI N/A
- EPS
- VXRT N/A
- OCCI N/A
- Revenue
- VXRT $13,928,000.00
- OCCI N/A
- Revenue This Year
- VXRT $67.68
- OCCI N/A
- Revenue Next Year
- VXRT N/A
- OCCI $10.19
- P/E Ratio
- VXRT N/A
- OCCI N/A
- Revenue Growth
- VXRT 577.76
- OCCI N/A
- 52 Week Low
- VXRT $0.52
- OCCI $5.47
- 52 Week High
- VXRT $1.54
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- VXRT 48.09
- OCCI 44.68
- Support Level
- VXRT $0.77
- OCCI $7.39
- Resistance Level
- VXRT $0.83
- OCCI $7.48
- Average True Range (ATR)
- VXRT 0.05
- OCCI 0.06
- MACD
- VXRT -0.00
- OCCI -0.01
- Stochastic Oscillator
- VXRT 32.00
- OCCI 25.00
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.